Results 151 to 160 of about 133,468 (309)

Lung organoids as a human system for Mycobacteria infection modeling and drug testing

The FEBS Journal, EarlyView.
Mycobacterial infections, including tuberculosis (TB) and infections by nontuberculous mycobacteria (NTM), are still public health issues. In 2023, TB caused 1.25 million deaths, while NTM remain a clinical challenge for patients with cystic fibrosis (CF).
Stephen Adonai Leon‐Icaza, Romain Vergé, Raoul Mazars, Laurence Berry, Céline Cougoule   +4 more
wiley   +1 more source

Twelve–Year Follow–Up of A Prospective Randomized Trial of Hepatitis B Recombinant Dna Yeast Vaccine Versus Plasma–Derived Vaccine Without Booster Doses in Children [PDF]

, 1999
Man‐Fung Yuen, Wei-Ling Lim, Chi-Chung Cheng, Shiu-Kam Lam, Ching‐Lung Lai   +4 more
openalex   +1 more source

Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK [PDF]

, 2013
Alderton, W K, Anderson, Rosaleen, Collingwood, S P, Pryde, D C   +3 more
core   +1 more source

Enrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever Vaccine

, 2013
This investigation evaluated several factors associated with diverse participant enrollment of a clinical trial assessing safety, immunogenicity, and comparative viremia associated with administration of 17-D live, attenuated yellow fever vaccine given ...
Edupuganti, Srilatha, Frew, Paula M., Keyserling, Harry L., Lu, Lu, Mulligan, Mark J., Shapiro, Eve T.   +5 more
core   +1 more source

Protein nanoparticles assemble in plants, display antigenic viral peptides, and produce an epitope‐specific immune response

The FEBS Journal, EarlyView.
Current methods to control porcine reproductive and respiratory syndrome, a disease affecting pigs, are insufficient and a safer, more effective vaccine is needed. This study describes the design and plant production of a self‐assembling protein nanoparticle vaccine candidate against this disease.
Jordan T. VanderBurgt, Richard Strasser, Hong Zhu, Angelo Kaldis, Christopher P. Garnham, Rima Menassa   +5 more
wiley   +1 more source

Mission 2030: Toward universal hepatitis B immunization

Human Vaccines & Immunotherapeutics
Despite the availability of efficacious and safe vaccines for more than 40 years, the rate of new hepatitis B virus (HBV) infections remains high, leaving large populations at risk of developing chronic hepatitis B, liver cirrhosis and cancer.
Elias Broeckhoven, Kai Dallmeier
doaj   +1 more source

Immunogenicity, safety, and tolerability of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young Japanese adults [PDF]

, 2018
Hiroyuki Kishino, Kenichi Takahashi, Miyuki Sawata, Yoshiyuki Tanaka   +3 more
openalex   +1 more source

Peer Review #1 of "The effectiveness of hepatitis B vaccine in toddlers based on the five-year period national basic health research (Riskesdas 2007, 2013 and 2018) in Indonesia (v0.1)"

, 2023

openalex   +1 more source

Perspectives on Pertussis Prevention

Acta Paediatrica, EarlyView.
Ulrich Heininger
wiley   +1 more source

Population‐Based Molecular Surveillance of Hepatitis B Virus Genotypes in the Goto Islands, Japan: A Three Decade Study (1977–2008) of 916 Carriers

Hepatology Research, EarlyView.
ABSTRACT Aims Understanding the molecular characteristics and genotype distribution of hepatitis B virus (HBV) is essential to elucidate intra and inter community transmission routes, identify cluster cases, and assess clinical implications based on genotype‐specific virulence.
Ko Ko, Golda Akuffo Ataa, Kazumi Yamasaki, Kazuhiro Hirase, Takahiro Yasaka, Satoshi Shirahama, Tomoyuki Akita, Aya Sugiyama, Shingo Fukuma, Kazuaki Takahashi, Junko Tanaka   +10 more
wiley   +1 more source